The influences of CYP2C9*1/*3 genotype on the pharmacokineticsof zolpidem
활용도 Analysis
논문 Analysis
연구자 Analysis
저자
변지영
김영훈
김세형
이충민
정의현
채원기
장춘곤
이석용
이윤정
제어번호
105927492
학술지명
Archives of Pharmacal Research
권호사항
Vol.
41
No.
9
[
2018
]
발행처
대한약학회
발행처 URL
http://www.psk.or.kr
자료유형
학술저널
수록면
931-936
(
6쪽)
언어
English
출판년도
2018
등재정보
KCI등재
소장기관
중앙대학교 서울캠퍼스 중앙도서관
중앙대학교 서울캠퍼스 중앙도서관
중앙대학교 서울캠퍼스 중앙도서관
판매처
'
The influences of CYP2C9*1/*3 genotype on the pharmacokineticsof zolpidem' 의 참고문헌
Zolpidem: an update of its pharmacology, therapeutic efficacy and tolerability in the treatment of insomnia
Zolpidem: a review of its use in the management of insomnia
Zolpidem: a nonbenzodiazepine hypnotic for treatment of insomnia
Zolpidem metabolism in vitro: responsible cytochromes, chemical inphibitors, and in vivo correlations
The safety and tolerability of zolpidem-an update
The pharmacology and mechanism of action of zolpidem
The contribution of intestinal and hepatic CYP3A to the interaction between midazolam and clarithromycin
Tamsulosin exposure is significantly increased by the CYP2D6*10/*10 genotype
Strongly increased exposure of meloxicam in CYP2C9*3/*3 individuals
Polymorphism of human cytochrome P450 enzymes and its clinical impact
Oxidative metabolism of zolpidem by human liver cytochrome P450S
Interethnic and intraethnic variability of CYP2C8 and CYP2C9 polymorphisms in healthy individuals
Inhibition of triazolam clearance by macrolide antimicrobial agents: in vitro correlates and dynamic consequences
Imidazopyridines as a tool for the characterization of benzodiazepine receptors: a proposal for a pharmacological classification as omega receptor subtypes
Frequency of CYP2C9 alleles in Koreans and their effects on losartan pharmacokinetics
Ethnic differences in CYP2C9*2 (Arg144Cys) and CYP2C9*3 (Ile359Leu) genotypes in Japanese and Israeli populations
Effects of the CYP2D6*10 allele on the pharmacokinetics of atomoxetine and its metabolites
Effects of the CYP2C9*1/*13 genotype on the pharmacokinetics of lornoxicam
Effects of CYP2C9*1/*3 genotype on the pharmacokinetics of flurbiprofen in Korean subjects
Effects of CYP2C9*1/*3 and *1/*13 on the pharmacokinetics of losartan and its active metabolite E-3174
Effects of CYP2C9*1/*13 on the pharmacokinetics and pharmacodynamics of meloxicam
Effect of the CYP2D6*10 allele on the pharmacokinetics of clomiphene and its active metabolites
Determination of zolpidem in human plasma by liquid chromatography-tandem mass spectrometry for clinical application
Cytochrome P450 2C9 polymorphisms: a comprehensive review of the in vitro and human data
CYP3A4 and CYP2C19 genetic polymorphisms and zolpidem metabolism in the Chinese Han population: a pilot study
CYP2C9*3 and *13 alleles significantly affect the pharmacokinetics of irbesartan in healthy Korean subjects
Biaxin (clarithromycin) prescribing information
Allele and genotype frequencies of CYP2C9 in a Korean population
A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential
'
The influences of CYP2C9*1/*3 genotype on the pharmacokineticsof zolpidem'
의 유사주제(
